{
    "title": "Santhera's drug gets US FDA nod for rare muscular dystrophy",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12677449/US-FDA-approves-Santheras-drug-rare-muscular-dystrophy.html",
    "date": "2023-10-26",
    "keywords": [
        "drug",
        "santhera",
        "dmd",
        "catalyst",
        "approval",
        "agamree",
        "company",
        "launch",
        "thursday",
        "health",
        "partner",
        "dystrophy",
        "market",
        "trading",
        "drugmaker",
        "manufacturing",
        "supply",
        "america",
        "payment",
        "equity",
        "investment",
        "food",
        "gene",
        "therapy",
        "musclewasting",
        "disorder",
        "manner",
        "prednisone",
        "standard",
        "care",
        "duschenne",
        "safety",
        "weight",
        "gain",
        "hair",
        "growth",
        "spokesperson",
        "information",
        "price",
        "product",
        "quarter",
        "midstage",
        "stage",
        "study",
        "efficacy",
        "standardofcare",
        "assistance",
        "program",
        "accessibility",
        "month",
        "decision",
        "authorization",
        "year",
        "reporting",
        "leo",
        "khushi",
        "mandowara",
        "pratik",
        "jain",
        "bengaluru",
        "editing",
        "maju",
        "samuel",
        "kuber"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}